Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages
Angewandte Chemie International Edition · 2023
DOI: 10.1002/anie.202310059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Chunlong Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1,…. Hauptthemen laut MEDLINE: Macrophages, Histone Deacetylases, Histone Deacetylase Inhibitors, Anti-Inflammatory Agents. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, China Sponsorship Council, HORIZON EUROPE Health.
Abstract (Originalsprache)
Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can activate pro‐inflammatory gene expression in lipopolysaccharide‐stimulated M1‐like macrophages and cannot be blocked by traditional small‐molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase‐independent function of HDAC3. We developed a potent and selective HDAC3‐directed PROTAC, P7 , which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP‐1 cells and human primary macrophages. P7 increases the anti‐inflammatory cytokine secretion in THP‐1‐derived M1‐like macrophages. Importantly, P7 decreases the secretion of pro‐inflammatory cytokines in M1‐like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0‐like into M1‐like macrophage. In conclusion, we demonstrate that the HDAC3‐directed PROTAC P7 has anti‐inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
- Department of Medical Microbiology and Infection Prevention, Tumor Virology and Cancer Immunotherapy, University Medical Center Groningen, University of Groningen Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherla…
ORCID-Profile: Chunlong Zhao, Deng Chen, Frank J Dekker
Förderung
- China Scholarship Council
- China Sponsorship Council
- HORIZON EUROPE Health
Zitieren
APA
Zhao, C., Chen, S., Chen, D., Río-Bergé, C., Zhang, J., Van Der Wouden, P. E., Daemen, T., & Dekker, F. J. (2023). Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202310059
Vancouver
Zhao C, Chen S, Chen D, Río-Bergé C, Zhang J, Van Der Wouden PE, et al. Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202310059
BibTeX
@article{Zhao2023,
author = {Zhao, Chunlong and Chen, Shipeng and Chen, Deng and Río-Bergé, Clàudia and Zhang, Jianqiu and Van Der Wouden, Petra E and Daemen, Toos and Dekker, Frank J},
title = {Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages},
journal = {Angewandte Chemie International Edition},
year = {2023},
doi = {10.1002/anie.202310059}
}
EUVIMED